Search Results - P. Fenaux
- Showing 1 - 12 results of 12
-
1
PB2352: CONSOLIDATION OF ERN-EUROBLOODNET: THE EUROPEAN REFERENCE NETWORK ON RARE HEMATOLOGICAL DISEASES FIRST 5 YEARS OF IMPLEMENTATION by M. D. M. Mañú Pereira, V. Gutierrez Valle, M. Pellegrini, M. D. L. Á. Rodríguez Sánchez, L. Margot, B. Gulbis, P. Fenaux
Published in HemaSphere (2022-06-01)Get full text
Article -
2
P727: NK-CELL IMMUNOEDITING BY MESENCHYMAL STROMAL CELLS IN MDS by V. Bisio, B. Schell, L.-P. Zhao, E. Lereclus, M. Boy, A. Bonaud, A. Caignard, A. Toubert, P. Fenaux, M. Espéli, K. Balabanian, L. Adès, N. Dulphy
Published in HemaSphere (2022-06-01)Get full text
Article -
3
P778: LONG-TERM UTILIZATION AND BENEFIT OF LUSPATERCEPT IN PATIENTS (PTS) WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) FROM THE MEDALIST TRIAL by P. Fenaux, V. Santini, R. S. Komrokji, A. Zeidan, G. Garcia-Manero, R. Buckstein, D. Miteva, K. Keeperman, N. Holot, J. Zhang, J. A. Nadal, B. Rosettani, A. Yucel, U. Platzbecker
Published in HemaSphere (2022-06-01)Get full text
Article -
4
B04 | OVERALL SURVIVAL AND DURATION OF TRANSFUSION INDEPENDENCE FOR FIRST-LINE ERYTHROPOIESIS STIMULATING AGENT-NAIVE PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES TREATED WIT... by V. Santini, M. Della Porta, A. Zeidan, R.S. Komrokji, V. Pozharskaya, S. Rose, K. Keeperman, Y. Lai, S. Kalsekar, B. Aggarwal, D. Miteva, D. Valcárcel, P. Fenaux, J. Shortt, U. Platzbecker, G. Garcia-Manero
Published in Haematologica (2025-09-01)Get full text
Article -
5
P728: GENE EXPRESSION PROFILE REVELS T-LYMPHOCYTES ACTIVATION THROUGH CELL CYCLE PROGRESSION AND MITOCHONDRIAL METABOLISM REGULATION IN MYELODYSPLASTIC SYNDROMES WITH DEL(5Q) AFTER... by M. del Rey, L. A. Corchete, T. González, F. López-Cadenas, E. Lumbreras, S. M. Toribio, B. Xicoy, J. Sánchez-García, T. Bernal, G. F. Sanz, P. Fenaux, J. M. Hernández-Rivas, M. Diez-Campelo
Published in HemaSphere (2022-06-01)Get full text
Article -
6
P768: GUADECITABINE (SGI-110) VS. TREATMENT CHOICE (TC) IN RELAPSED/REFRACTORY(R/R) MYELODYSPLASTIC SYNDROME (MDS), RESULTS OF A GLOBAL, RANDOMIZED, PHASE 3 STUDY. by G. Garcia-Manero, S. Bart, J. K. McCloskey, P. Fenaux, D. Selleslag, G. Reda, D. Valcárcel, V. Santini, J. Mayer, B. Xicoy, H. Yamaguchi, M. Lübbert, Y. Miyazaki, H. Keer, Y. Hao, M. Azab, H. Döhner
Published in HemaSphere (2022-06-01)Get full text
Article -
7
C052 | OUTCOMES OF IMETELSTAT THERAPY IN PATIENTS WITH RING SIDEROBLAST–NEGATIVE LOWER-RISK MYELODYSPLASTIC SYNDROMES FROM THE POOLED IMERGE STUDY POPULATIONS by V. Santini, U. Platzbecker, A.M. Zeidan, M.A. Sekeres, A. Raza, M. Mittelman, S. Thépot, R. Buckstein, U. Germing, Y. F. Madanat, M. Díez-Campelo, D. Valcárcel, A. Jonášová, S. Dougherty, Q. Xia, L. Sun, S. Navada, F. Feller, M.R. Savona, R.S. Komrokji, P. Fenaux
Published in Haematologica (2025-09-01)Get full text
Article -
8
PB1921: A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF TAMIBAROTENE/AZACITIDINE VERSUS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS (SELECT... by A. DeZern, G. Marconi, D. Deeren, M. Diez Campelo, M. Lübbert, P. Krishnamurthy, Z. Nagy, G. Basak, A. Jonášová, E. Morozova, K. Geissler, Y. Ofran, H. Kelley, A. Volkert, K. Baker, Q. Kang-Fortner, G. Hodgson, C. Madigan, D. A. Roth, M. Kelly, P. Fenaux
Published in HemaSphere (2022-06-01)Get full text
Article -
9
EFFICACY AND SAFETY OF LUSPATERCEPT VERSUS EPOETIN ALFA IN ERYTHROPOIESIS-STIMULATING AGENT (ESA)-NAIVE PATIENTS WITH TRANSFUSION-DEPENDENT LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR... by G. Garcia-Manero, U. Platzbecker, V. Santini, A. Zeidan, P. Fenaux, R. Komrokji, J. Shortt, D. Valcarcel, A. Jonasova, S. Dimicoli-Salazar, I.S. Tiong, C.-C. Lin, J. Li, J. Zhang, A.C. Giuseppi, S. Kreitz, V. Pozharskaya, K. Keeperman, S. Rose, T. Prebet, A. Degulys, S. Paolini, T. Cluzeau, M. Della Porta
Published in Leukemia Research Reports (2024-01-01)Get full text
Article -
10
S168: ERYTHROPOIETIN STIMULATION AGENTS SIGNIFICANTLY IMPROVES OUTCOME IN LOWER RISK MDS. by H. Garelius, A. Smith, T. Bagguley, A. Taylor, P. Fenaux, D. Bowen, A. Symeonidis, M. Mittelmann, R. Stauder, J. Čermák, G. Sanz, S. Langemeijer, L. Malcovati, U. Germing, R. Itzykson, A. Guerci-Bresler, D. Culligan, I. Kotsianidis, K. Koinig Mag, C. van Marrewijk, S. Crouch, T. de Witte, E. Hellström-Lindberg
Published in HemaSphere (2022-06-01)Get full text
Article -
11
S169: CLINICAL AND MOLECULAR MARKERS FOR PREDICTING RESPONSE TO ROMIPLOSTIM TREATMENT IN LOWER-RISK MYELODYSPLASTIC SYNDROMES by A. S. Kubasch, A. Giagounidis, G. Metzgeroth, A. Jonasova, R. Herbst, J. M. T. Diaz, B. De Renzis, K. S. Götze, M.-L. Huetter-Kroenke, M.-P. Gourin, B. Slama, S. Dimicoli-Salazar, P. Cony-Makhoul, K. Laribi, S. Park, K. Jersemann, D. Schipp, K. H. Metzeler, O. Tiebel, K. Sockel, S. Gloaguen, A. Mies, F. Chermat, C. Thiede, R. Sapena, R. F. Schlenk, P. Fenaux, U. Platzbecker, L. Ades
Published in HemaSphere (2022-06-01)Get full text
Article -
12
C053 | REAL-WORLD, MULTI-OMICS VALIDATION OF THE CLINICAL RELEVANCE OF MOLECULAR TAXONOMY FOR MYELODYSPLASTIC SYNDROMES. AN INTERNATIONAL STUDY ON BEHALF OF GENOMED4ALL, SYNTHEMA A... by G. Maggioni, G. Todisco, E. Sauta, L. Lanino, S. Ball, Jp Bewersdorf, T Kewan, Nh Al Ali, P. Fenaux, U Platzbecker, V. Santini, Z Xie, AM. Brunner, At Kuykendall, JM. Bennett, R. Buckstein, R. Bejar, He Carraway, Ae Dezern, Ea Griffiths, S. Halene, Rp Hasserjian, Af List, S. Loghavi, O Odenike, E. Padron, MM. Patnaik, Gj Roboz, Maximilian Stahl, Ma Sekeres, Dp Steensma, Mr Savona, J Taylor, Ml Xu, Da Sallman, Sd Nimer, Cs Hourigan, Ah Wei, A. Campagna, M. Ubezio, E. Riva, D. Ventura, N. Pinocchio, M. Zampini, A. Buizza, A. Russo, F. Pesce, G. Asti, M. Delleani, E. Travaglino, Ca Tentori, I. Ferrari, A. Crespi, G. Figini, M. Di Matteo, M. Brindisi, L. Crisafulli, F. Ficara, G. Castellani, UM. Borate, F. Efficace, Sd Gore, Tk Kim, Aa Van De Loosdrecht, N. Daver, M. Rozman, A. Orfao, Sa Wang, K Foucar, M. Iastrebner, P. Scheinberg, Y Miyazaki, M. Mittelmann, T Cluzeau, L. Ades, U Germing, S. Kordasti, T Haferlach, AM. Zeidan, Rs Komrokji, Mg Della Porta.
Published in Haematologica (2025-09-01)Get full text
Article
